Among more than 140,000 visits for ear infection, only 15% used watchful waiting, but treatment failure rates were low and ...
Half of the Staphylococcus epidermidis isolates found in raw milk from dairy cattle and sheep were multidrug resistant.
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Animal tests show promise to target invasive strain of E. coli but approval for use in humans is still years away ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...
Live Science on MSN
Antibiotic found hiding in plain sight could treat dangerous infections, early study finds
Scientists have discovered a never-before-seen antibiotic that shows promising in treating drug-resistant infections.
Lethal lettuce in Missouri. Murderous onions in Colorado. To biochemists at the University of Oklahoma, these aren't just ...
Ashtabula Area City School District sued Liberty Mutual Fire Insurance Company in federal court this month, alleging the ...
Discover Magazine on MSN
New Antibiotic Could be 100 Times More Potent and Has Potential to Save Countless Lives
Learn how chemists were studying a known antibiotic when they discovered a molecule 100 times more potent at defeating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback